Recursion Pharmaceuticals Inc (RXRX)
6.40
+0.08
(+1.27%)
USD |
NASDAQ |
Nov 01, 16:00
6.405
0.00 (0.00%)
After-Hours: 20:00
Recursion Pharmaceuticals Total Liabilities (Quarterly): 191.41M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 191.41M |
| March 31, 2024 | 156.70M |
| December 31, 2023 | 190.26M |
| September 30, 2023 | 192.86M |
| June 30, 2023 | 197.74M |
| March 31, 2023 | 197.19M |
| December 31, 2022 | 215.48M |
| September 30, 2022 | 223.50M |
| Date | Value |
|---|---|
| June 30, 2022 | 234.94M |
| March 31, 2022 | 240.75M |
| December 31, 2021 | 67.41M |
| September 30, 2021 | 59.57M |
| June 30, 2021 | 55.88M |
| March 31, 2021 | 504.97M |
| December 31, 2020 | 504.87M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
55.88M
Minimum
Jun 2021
504.97M
Maximum
Mar 2021
215.57M
Average
197.19M
Median
Mar 2023
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly and Co | 61.29B |
| Pfizer Inc | 128.22B |
| Revance Therapeutics Inc | 624.54M |
| Twist Bioscience Corp | 146.98M |
| NovaBay Pharmaceuticals Inc | 4.542M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 775.86M |
| Shareholders Equity (Quarterly) | 584.45M |
| Debt to Equity Ratio | 0.0531 |
| Current Ratio | 6.068 |
| Net Debt Paydown Yield | -0.28% |